Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies
Abstract
Share and Cite
Herrera-Ramirez, A.; Yepes-Pérez, A.F.; Quintero-Saumeth, J.; Moreno-Quintero, G.; Naranjo, T.W.; Cardona-Galeano, W. Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies. Sci. Pharm. 2022, 90, 40. https://doi.org/10.3390/scipharm90030040
Herrera-Ramirez A, Yepes-Pérez AF, Quintero-Saumeth J, Moreno-Quintero G, Naranjo TW, Cardona-Galeano W. Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies. Scientia Pharmaceutica. 2022; 90(3):40. https://doi.org/10.3390/scipharm90030040
Chicago/Turabian StyleHerrera-Ramirez, Angie, Andres F. Yepes-Pérez, Jorge Quintero-Saumeth, Gustavo Moreno-Quintero, Tonny W. Naranjo, and Wilson Cardona-Galeano. 2022. "Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies" Scientia Pharmaceutica 90, no. 3: 40. https://doi.org/10.3390/scipharm90030040
APA StyleHerrera-Ramirez, A., Yepes-Pérez, A. F., Quintero-Saumeth, J., Moreno-Quintero, G., Naranjo, T. W., & Cardona-Galeano, W. (2022). Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies. Scientia Pharmaceutica, 90(3), 40. https://doi.org/10.3390/scipharm90030040

